Julie Gralow: Nice summary of my testimony of behalf of ASCO in House Ways and Means Committee hearing on drug shortages earlier this month

Julie Gralow shared a post by Cancer Therapy Advisor on X, adding the following:

“Nice summary of my testimony of behalf of ASCO in House Ways and Means Committee hearing on drug shortages earlier this month.”

Quoting Cancer Therapy Advisor’s post:

“The Federal Trade Commission (FTC) and U.S. Department of Health & Human Services (HHS) say they are attempting to uncover the causes of generic drug shortages and identify potential solutions to end these shortages. With Julie Gralow from
ASCO.”

Read further.
Source: Julie Gralow/X and Cancer Therapy Advisor/X

Julie Gralow is the Chief Medical Officer (CMO) and Executive Vice President of the American Society of Clinical Oncology (ASCO). Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN). Dr. Gralow received the ASCO Humanitarian Award in 2018 for her work in empowering women cancer patients and survivors globally.